Loading...

quantusRT

High-precision image diagnosis

Personalized clinical service

Our test offers safety and accuracy without being invasive

Predicts risk of skin lesion malignancy

WEB SERVICES RESTFUL

Compatible HL7 FHIR
logo

About us

quantusRT is a non-invasive, fast and easy-to-use test for the detection of malignant dermatological lesions from dermoscopic images. Its technology is based on quantitative analysis of dermoscopic image texture. By simply analyzing and classifying images, quantusRT determines the risk of skin lesion malignancy within minutes.

quantusRT has been designed with a clear focus on the diabetic general, and is intended as a tool for the detection of malignant skin lesions (melanoma, basal cell carcinoma or squamous cell carcinoma), being of great help in the screening of patients with risk factors and prioritization of waiting lists.

quantusRT classifies skin lesions as either benign or malignant, without (or in addition to) the need for visual inspection by a specialist using a dermatoscope. The specialist, always trained, classifies the images by visual patterns and quantusRT gives a percentage risk of malignancy.

Personalized medicine

quantusRT is presented as an easy-to-use web application for specialists that allows them to upload dermoscopic images for automatic analysis and receive reliable results within minutes.

60

Countries

700

Clinics

98
%

Positive opinions

115
k

Happy clients

ADVANTAGES OF QUANTUSRT

Our patients have access to have their quantusRT test performed in a wide network of clinics. You can contact us directly so that we can tell you which clinic is closest to you and you can have the test performed. The specialists will provide you with a detailed report.

Non invasive

Our test is non-invasive, it is performed with a simple dermatoscopic image obtained with a smartphone or reflex camera.

Reliable

quantusRT is a test that has excellent sensitivity and specificity values.

Fast

You will receive your report in the same office in a matter of minutes.

HL7

COMPATIBLE HL7

quantusFLM supports the HL7 FHIR protocol through its REST services.

Testimonials of customers

1. You buy the test through this page and you receive the authorization code in your email.
2. You look for the nearest center where you can take the test, you will receive the list in an email, or ask us and we will inform you.
3. You call the center and schedule an appointment for the test.
4. You go to the center on the appointed day and show the authorization code. They will take a dermatoscopic photograph in order to perform the test and will give you the result report immediately.

The test you purchase on this page includes:
- Dermatoscopic image analysis.
- Result report in electronic format.

The test does not include:
- The doctor's consultation (ask the doctor about the possible cost)
- Other complementary tests

quantusRT has been designed with a clear focus on the diabetic general and is intended to be a tool for the detection of malignant skin lesions, being of great help in the screening of patients at risk and prioritization of waiting lists. Therefore, anyone can take the test at any time.

You can discuss with your doctor the existence of quantusRT and if you want to take the test you can go to one of the referenced centers where they will give you a report that you can then send to your doctor to be included in your medical record.

If your doctor wants to have more information about quantusRT and wants to try it, he/she only has to consult the web page www.quantusRT.com where he/she will have all the clinical information.

We have at your disposal professionals who will guide you to tell you which clinic you should go to for your test. Contact us by e-mail at info@transmuralbiotech.com or by phone at 931190229 and 626667989.